Literature DB >> 22364961

Estimating postprandial glucose fluxes using hierarchical Bayes modelling.

Ahmad Haidar1, Elizabeth Potocka, Benoit Boulet, A Margot Umpleby, Roman Hovorka.   

Abstract

A new stochastic computational method was developed to estimate the endogenous glucose production, the meal-related glucose appearance rate (R(a meal)), and the glucose disposal (R(d)) during the meal tolerance test. A prior probability distribution was adopted which assumes smooth glucose fluxes with individualized smoothness level within the context of a Bayes hierarchical model. The new method was contrasted with the maximum likelihood method using data collected in 18 subjects with type 2 diabetes who ingested a mixed meal containing [U-¹³C]glucose. Primed [6,6-²H₂]glucose was infused in a manner that mimicked the expected endogenous glucose production. The mean endogenous glucose production, R(a meal), and R(d) calculated by the new method and maximum likelihood method were nearly identical. However, the maximum likelihood gave constant, nonphysiological postprandial endogenous glucose production in two subjects whilst the new method gave plausible estimates of endogenous glucose production in all subjects. Additionally, the two methods were compared using a simulated triple-tracer experiment in 12 virtual subjects. The accuracy of the estimates of the endogenous glucose production and R(a meal) profiles was similar [root mean square error (RMSE) 1.0±0.3 vs. 1.4±0.7 μmol/kg/min for EGP and 2.6±1.0 vs. 2.9±0.9 μmol/kg/min for R(a meal); new method vs. maximum likelihood method; P=NS, paired t-test]. The accuracy of R(d) estimates was significantly increased by the new method (RMSE 5.3±1.9 vs. 4.2±1.3; new method vs. ML method; P<0.01, paired t-test). We conclude that the new method increases plausibility of the endogenous glucose production and improves accuracy of glucose disposal compared to the maximum likelihood method.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364961     DOI: 10.1016/j.cmpb.2012.01.010

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  5 in total

1.  Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.

Authors:  D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; L Leelarathna; C L Acerini; A Haidar; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Diabetologia       Date:  2013-02-23       Impact factor: 10.122

2.  Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.

Authors:  Joseph El Youssef; Jessica R Castle; Parkash A Bakhtiani; Ahmad Haidar; Deborah L Branigan; Matthew Breen; W Kenneth Ward
Journal:  Diabetes Care       Date:  2014-08-19       Impact factor: 19.112

3.  Validity of triple- and dual-tracer techniques to estimate glucose appearance.

Authors:  A Haidar; D Elleri; J M Allen; J Harris; K Kumareswaran; M Nodale; C L Acerini; M E Wilinska; N Jackson; A M Umpleby; M L Evans; D B Dunger; R Hovorka
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

4.  Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.

Authors:  Martin B Whyte; Fariba Shojaee-Moradie; Sharaf E Sharaf; Nicola C Jackson; Barbara Fielding; Roman Hovorka; Jeewaka Mendis; David Russell-Jones; A Margot Umpleby
Journal:  J Clin Endocrinol Metab       Date:  2019-02-01       Impact factor: 5.958

5.  Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.

Authors:  D Elleri; M Biagioni; J M Allen; K Kumareswaran; L Leelarathna; K Caldwell; M Nodale; M E Wilinska; A Haidar; P Calhoun; C Kollman; N C Jackson; A M Umpleby; C L Acerini; D B Dunger; R Hovorka
Journal:  Diabetes Obes Metab       Date:  2015-10-09       Impact factor: 6.577

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.